Management of glioblastoma: an Australian perspective

Chin Clin Oncol. 2021 Aug;10(4):42. doi: 10.21037/cco.2020.02.05. Epub 2020 Feb 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Australia
  • Dacarbazine
  • Glioblastoma* / therapy
  • Humans
  • Temozolomide

Substances

  • Dacarbazine
  • Temozolomide